Investigational New Drugs

, Volume 15, Issue 1, pp 29–37

Angiogenic factors as tumor markers

  • Mai Nguyen


The process of angiogenesis plays a critical role in tumor growth and metastasis. Recently, there has been much interest in the possible use of angiogenic growth factors as tumor markers. This paper will review the results thus far of attempts at measuring various angiogenic factors in bodily fluids. In the future, angiogenic factors will most likely be useful as a monitor of therapy and/or a predictor of outcome after cancer has been diagnosed.

angiogenesis angiogenic factor tumor marker serum urine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27–31, 1995Google Scholar
  2. 2.
    Folkman J: Tumor angiogenesis. In: Mendelsohn J, Holwey PM, Israel MA, Liotta LA (eds). The molecular basis of cancer. WB Saunders, 1995, pp 206–232Google Scholar
  3. 3.
    Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. New Engl J Med 324:1–8, 1991Google Scholar
  4. 4.
    Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Presented at a national meeting on New cancer strategies: angiogenesis antagonists, Washington DC, 1995Google Scholar
  5. 5.
    Chodak GW, Scheiner CJ, Zetter BR: Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. New Eng J Med 305:869–874, 1981Google Scholar
  6. 6.
    Watanabe H, Hori A, Seno M, Kozai Y, Igarashi K, Ichimori Y, Kondo K: A sensitive enzyme immunoassay for human basic fibroblast growth factor. Biochem Biophys Res Comm 175:229–235, 1991Google Scholar
  7. 7.
    Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T, Terada M: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Comm 180:386–392, 1991Google Scholar
  8. 8.
    Fujimoto K, Ichimori Y, Yamaguchi H, Arai K, Futami T, Ozono S, Hirao Y, Kakizoe T, Terada M, Okajima E: Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn J Cancer Res 86:182–186, 1995Google Scholar
  9. 9.
    Nguyen M, Watanabe H, Budson AE, Richic JP, Hayes DF, Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancer. J Natl Cancer Inst 86:356–361, 1994Google Scholar
  10. 10.
    Nguyen M, Watanabe H, Budson AE, Richie JP, Folkman J: Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Nat Cancer Inst 85:241–242, 1993Google Scholar
  11. 11.
    Watanabe H, Nguyen M, Schizer M, Li V, Hayes D, Sallan S, Folkman J: Basic fibroblast growth factor in human serum — A prognostic test for breast cancer (Abstract). Molec Biol Cell 3S:234a, 1992Google Scholar
  12. 12.
    Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, Friesen HG: Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: Relation to pituitary tumor. J Clin Endocrin Metab 76:1182–1187, 1993Google Scholar
  13. 13.
    O'Brien TS, Smith K, Cranston D, Fuggle S, Bicknell R, Harris AL: Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol 76:311–314, 1995Google Scholar
  14. 14.
    Lin RY, Argenta PA, Sullivan KM, Adzick NS: Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin Cancer Res 1:327–331, 1995Google Scholar
  15. 15.
    Chopin DK, Caruelle JP, Colombel M, Palcy S, Ravery V, Caruelle D, Abbou CC, Barritault D: Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urology 150:1126–1130, 1993Google Scholar
  16. 16.
    Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Let 94:227–231, 1995Google Scholar
  17. 17.
    Takei Y, Kurobe M, Uchida A, Hayashi K: Serum concentrations of basic fibroblast growth factor in breast cancer. Clin Chem 40:1980–1981, 1994Google Scholar
  18. 18.
    Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82–86, 1994Google Scholar
  19. 19.
    Kondo S, Asano M, Matsuo K, Ohmori I, Suzui H: Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochem Biophys Acta 1221:211–214, 1994Google Scholar
  20. 20.
    Kanno H, Chiba Y, Kyuma Y, Hayashi A, Abe H, Takada H, Kim I, Yamamoto I: Urinary epidermal growth factor in patients with gliomas: significance of the factor as a glial tumor marker. J Neurosurg 79:408–413, 1993Google Scholar
  21. 21.
    Chuang LY, Hung WC, Yang ML, Chang CC, Tsai JF: Urinary epidermal growth factor receptor-binding growth factors in patients with cancers of the digestive tract. Clin Biochem 27:485–489, 1994Google Scholar
  22. 22.
    Uchihashi M, Hirata Y, Nakajim H, Fujita T, Matsukura S: Urinary excretion of human epidermal growth factor (hEGF) in patients with malignant tumors. Horm Metab Res 15:261–262, 1983Google Scholar
  23. 23.
    Chow NH, Tzai TS, Cheng PE, Chang CJ, Lin JSN, Tang MJ: An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 22:221–225, 1994Google Scholar
  24. 24.
    Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW: The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occ Med 36:1324–1328, 1994Google Scholar
  25. 25.
    Ridderheim M, Cajander S, Tavelin B, Stendahl U, Backstrom T: EGF/TGF-α and progesterone in urine of ovarian cancer patients. Antic Res 14:2119–2124, 1994Google Scholar
  26. 26.
    Chakrabarty S, Huang S, Moskal TL, Fritsche HA: Elevated serum levels of transforming growth factor-α in breast cancer patients. Cancer Let 79:157–160, 1994Google Scholar
  27. 27.
    Stromberg K, Duffy M, Fritsch C, Hudgins R, Sharp ES, Murphy LD, Lippman ME, Bates SE: Comparison of urinary transforming growth factor-α in women with disseminated breast cancer and healthy control women. Cancer Det Prev 15:277–283, 1991Google Scholar
  28. 28.
    Moskal TL, Huang S, Ellis LM, Fritsche HA, Chakrabarty S: Serum levels of transforming growth factor α in gastrointestinal cancer patients. Cancer Epid Biom Prev 4:127–131, 1995Google Scholar
  29. 29.
    Fazekas-May M, Suen JY, Yeh YC, Yeh HW, Milligan LB: Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck. Head Neck 12:411–416, 1990Google Scholar
  30. 30.
    Eder IE, Stenzl A, Cronauer MV, Bartsch G, Klocker H: Transforming growth factor-β1 and-β2 and basic fibroblast growth factor in serum and urine from patients with bladder cancer (Abstract). Proc Am Assoc Cancer Res 36:1461, 1995Google Scholar
  31. 31.
    Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaugnessy P, Goldberg ID, Rosen EM: Expression of scatter factor in human bladder carcinoma. J Nat Cancer Inst 87:372–377, 1995Google Scholar
  32. 32.
    Moradi MM, Carson LF, Winberg JB, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72:2433–2440, 1993Google Scholar
  33. 33.
    Ueda T, Shimada E, Urakawa T: Serum levels of cytokines in patiets with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423–429, 1994Google Scholar
  34. 34.
    Nguyen M, Strubel N, Bischoff J: A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269, 1993Google Scholar
  35. 35.
    Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517–519, 1995Google Scholar
  36. 36.
    Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ: Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68:122–124, 1993Google Scholar
  37. 37.
    Hill DJ, Tevaarwerk GJM, Arany E, Kilkenny D, Gregory M, Langford KS, Miell J: Fibroblast growth factor 2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. J Clin Endocrin Metab 80:1822–1831, 1995Google Scholar
  38. 38.
    Hill DJ, Tevaarwerk GJM, Caddell C, Arany E, Kilkenny D, Gregory M: Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrin Metab 80:2626–2632, 1995Google Scholar
  39. 39.
    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl J Med 331:1480–1487, 1994Google Scholar
  40. 40.
    Newman W, Beall LD, Carson CW, Hunter GG, Graben N, Rndhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150(2):644–654, 1993Google Scholar
  41. 41.
    D'Amore PA, Brown RH, Ku PT, Hoffman EP, Watanabe H, Arahata K, Ishihara T, Folkman J: Elevated basic fibroblast growth factor in the serum of patients with Duchenne Muscular Dystrophy. Ann Neurol 35:362–365, 1994Google Scholar
  42. 42.
    Nakazaki H: Preoperative and postoperative cytokines in patients with cancer. Cancer 70:709–713, 1992Google Scholar
  43. 43.
    Soutter AD, Nguyen M, Watanabe H, Folkman J: Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 53:5297–5299, 1993Google Scholar
  44. 44.
    Cooper CS, See WA: The impact of iatrogenic urothelial trauma on urinary levels of transforming growth factor-alpha. J Urol 147:1647–1649, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Mai Nguyen
    • 1
  1. 1.SurgeryUniversity of CaliforniaLos AngelesUSA

Personalised recommendations